FDA Inspection 952436 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 3005680856

The FDA completed an inspection of New York Blood Center Enterprises on December 2, 2015 in Port Jefferson Station, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 2, 2015
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Port Jefferson Station, NY (United States)